Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amifostine vs. No Treatment for Platinum Induced Peripheral Neuropathy
NCT00058071Phase 3Completed
- Sponsor
- GOG Foundation
- Start
- Mar 2003
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amifostine in peripheral neuropathy, sponsored by GOG Foundation. Started Mar 2003; status: completed.
02
Drugs
amifostine
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT00058071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00058071.